Classification Information
a house mark for pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; a house mark for pharmaceutical preparations for the treatment of renal diseases and disorders; a house mark for pharmaceutical preparations for increasing bicarbonate levels; a house mark for non- absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; a house mark for polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders
Pharmaceuticals